Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 6
Submit an article Journal homepage
2,264
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis

Vibeke Stranda Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USAView further author information
,
Lixia Zhangb Scipher Medicine Corporation, Waltham, MA, USAView further author information
,
Alix Arnaudb Scipher Medicine Corporation, Waltham, MA, USAView further author information
,
Erin Connolly-Strongb Scipher Medicine Corporation, Waltham, MA, USAView further author information
,
Sam Asgarianb Scipher Medicine Corporation, Waltham, MA, USAView further author information
&
Johanna B Withersb Scipher Medicine Corporation, Waltham, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1289-4454View further author information
ORCID Icon
Pages 801-807 | Received 27 Feb 2022, Accepted 13 Apr 2022, Published online: 23 Apr 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.